GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » China National Medicines Corp Ltd (SHSE:600511) » Definitions » Cyclically Adjusted Revenue per Share

China National Medicines (SHSE:600511) Cyclically Adjusted Revenue per Share : ¥53.68 (As of Mar. 2024)


View and export this data going back to 2002. Start your Free Trial

What is China National Medicines Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

China National Medicines's adjusted revenue per share for the three months ended in Mar. 2024 was ¥16.065. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is ¥53.68 for the trailing ten years ended in Mar. 2024.

During the past 12 months, China National Medicines's average Cyclically Adjusted Revenue Growth Rate was 8.00% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 10.40% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 12.10% per year. During the past 10 years, the average Cyclically Adjusted Revenue Growth Rate was 16.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of China National Medicines was 21.80% per year. The lowest was 10.40% per year. And the median was 19.10% per year.

As of today (2024-05-23), China National Medicines's current stock price is ¥34.53. China National Medicines's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was ¥53.68. China National Medicines's Cyclically Adjusted PS Ratio of today is 0.64.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of China National Medicines was 3.43. The lowest was 0.52. And the median was 1.09.


China National Medicines Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for China National Medicines's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China National Medicines Cyclically Adjusted Revenue per Share Chart

China National Medicines Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 35.13 39.00 43.95 48.59 52.53

China National Medicines Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 49.49 50.34 51.68 52.53 53.68

Competitive Comparison of China National Medicines's Cyclically Adjusted Revenue per Share

For the Medical Distribution subindustry, China National Medicines's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


China National Medicines's Cyclically Adjusted PS Ratio Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, China National Medicines's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where China National Medicines's Cyclically Adjusted PS Ratio falls into.



China National Medicines Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, China National Medicines's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=16.065/115.2271*115.2271
=16.065

Current CPI (Mar. 2024) = 115.2271.

China National Medicines Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 6.011 98.200 7.053
201409 6.183 98.900 7.204
201412 6.251 99.000 7.276
201503 6.138 99.900 7.080
201506 6.266 99.500 7.256
201509 6.541 100.500 7.500
201512 6.280 100.600 7.193
201603 6.827 102.200 7.697
201606 14.769 101.400 16.783
201609 12.883 102.400 14.497
201612 12.989 102.600 14.588
201703 11.902 103.200 13.289
201706 13.103 103.100 14.644
201709 12.292 104.100 13.606
201712 12.016 104.500 13.249
201803 11.906 105.300 13.028
201806 12.570 104.900 13.807
201809 13.045 106.600 14.101
201812 13.006 106.500 14.072
201903 13.145 107.700 14.064
201906 14.357 107.700 15.360
201909 15.289 109.800 16.045
201912 15.817 111.200 16.390
202003 10.883 112.300 11.167
202006 12.352 110.400 12.892
202009 15.348 111.700 15.833
202012 14.935 111.500 15.434
202103 13.709 112.662 14.021
202106 15.549 111.769 16.030
202109 16.192 112.215 16.627
202112 16.139 113.108 16.441
202203 14.659 114.335 14.773
202206 14.508 114.558 14.593
202209 16.614 115.339 16.598
202212 14.522 115.116 14.536
202303 14.880 115.116 14.894
202306 17.113 114.558 17.213
202309 16.422 115.339 16.406
202312 17.451 114.781 17.519
202403 16.065 115.227 16.065

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


China National Medicines  (SHSE:600511) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

China National Medicines's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=34.53/53.68
=0.64

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of China National Medicines was 3.43. The lowest was 0.52. And the median was 1.09.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


China National Medicines Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of China National Medicines's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


China National Medicines (SHSE:600511) Business Description

Traded in Other Exchanges
N/A
Address
No. 12 A, Sanyuan West Lane, Yongwai, Chongwen District, Beijing, CHN, 100077
China National Medicines Corp Ltd focuses on producing special drugs and high-end prescription drugs. Its main goal is to provide customers with professional medical services. The company is also engaged in proprietary Chinese medicines, Chinese medicine decoction pieces, Chinese medicinal materials, chemical preparations, chemical raw materials, antibiotics, and biochemical drugs.

China National Medicines (SHSE:600511) Headlines

No Headlines